Publications
196 found
Show per page
Ebrahimi, F., Hubacher, S., Christ, E., & Zechmann, S. (2025). Pitstop approach: diabetologist referral and quality of care in patients with type 2 diabetes – a Swiss longitudinal study [Journal-article]. Swiss Medical Weekly, 155(8), 4031. https://doi.org/10.57187/s.4031
Ebrahimi, F., Hubacher, S., Christ, E., & Zechmann, S. (2025). Pitstop approach: diabetologist referral and quality of care in patients with type 2 diabetes – a Swiss longitudinal study [Journal-article]. Swiss Medical Weekly, 155(8), 4031. https://doi.org/10.57187/s.4031
Hepprich, Matthias, Romberg, Christina, Mudry, Jonathan, Refardt, Julie, Wild, Damian, Antwi, Kwadwo, & . (2025). Exenatide for diagnosing endogenous hyperinsulinemic hypoglycemia: a randomized placebo-controlled, double-blind, cross-over proof-of-principle study. European Journal of Endocrinology, 193(2), 247–254. https://doi.org/10.1093/ejendo/lvaf153
Hepprich, Matthias, Romberg, Christina, Mudry, Jonathan, Refardt, Julie, Wild, Damian, Antwi, Kwadwo, & . (2025). Exenatide for diagnosing endogenous hyperinsulinemic hypoglycemia: a randomized placebo-controlled, double-blind, cross-over proof-of-principle study. European Journal of Endocrinology, 193(2), 247–254. https://doi.org/10.1093/ejendo/lvaf153
Siebenhüner, A. R., Refardt, J., Nicolas, G. P., Kaderli, R., Walter, M. A., Perren, A., & Christ, E. (2025). Impact of multikinase inhibitors in reshaping the treatment of advanced gastroenteropancreatic neuroendocrine tumors [Journal-article]. Endocrine-Related Cancer, 32(6). https://doi.org/10.1530/erc-25-0052
Siebenhüner, A. R., Refardt, J., Nicolas, G. P., Kaderli, R., Walter, M. A., Perren, A., & Christ, E. (2025). Impact of multikinase inhibitors in reshaping the treatment of advanced gastroenteropancreatic neuroendocrine tumors [Journal-article]. Endocrine-Related Cancer, 32(6). https://doi.org/10.1530/erc-25-0052
Andereggen, Lukas, Gralla, Jan, & . (2024). The diagnostic yield of inferior petrosal sinus sampling in Cushing syndrome in the era of ovine CRH shortage. Acta Neurochirurgica, 166(1). https://doi.org/10.1007/s00701-024-06058-2
Andereggen, Lukas, Gralla, Jan, & . (2024). The diagnostic yield of inferior petrosal sinus sampling in Cushing syndrome in the era of ovine CRH shortage. Acta Neurochirurgica, 166(1). https://doi.org/10.1007/s00701-024-06058-2
Andereggen, Lukas, Tortora, Angelo, Schubert, Gerrit A., Musahl, Christian, Frey, Janine, Stieger, Andrea, Kobel, Béatrice, Luedi, Markus M., Roethlisberger, Michel, Mariani, Luigi, Beck, Jürgen, & . (2024). Characteristics and outcomes of men with erectile dysfunction as the presenting symptom due to a lactotroph adenoma. Acta Neurochirurgica, 166(1). https://doi.org/10.1007/s00701-024-06213-9
Andereggen, Lukas, Tortora, Angelo, Schubert, Gerrit A., Musahl, Christian, Frey, Janine, Stieger, Andrea, Kobel, Béatrice, Luedi, Markus M., Roethlisberger, Michel, Mariani, Luigi, Beck, Jürgen, & . (2024). Characteristics and outcomes of men with erectile dysfunction as the presenting symptom due to a lactotroph adenoma. Acta Neurochirurgica, 166(1). https://doi.org/10.1007/s00701-024-06213-9
Rottenburger, Christof, Hentschel, Michael, Fürstner, Markus, McDougall, Lisa, Kottoros, Danijela, Kaul, Felix, Mansi, Rosalba, Fani, Melpomeni, Vija, A. Hans, Schibli, Roger, Geistlich, Susanne, Behe, Martin, , & Wild, Damian. (2024). In-vivo inhibition of neutral endopeptidase 1 results in higher absorbed tumor doses of [177Lu]Lu-PP-F11N in humans: the lumed phase 0b study. EJNMMI Research, 14(1). https://doi.org/10.1186/s13550-024-01101-w
Rottenburger, Christof, Hentschel, Michael, Fürstner, Markus, McDougall, Lisa, Kottoros, Danijela, Kaul, Felix, Mansi, Rosalba, Fani, Melpomeni, Vija, A. Hans, Schibli, Roger, Geistlich, Susanne, Behe, Martin, , & Wild, Damian. (2024). In-vivo inhibition of neutral endopeptidase 1 results in higher absorbed tumor doses of [177Lu]Lu-PP-F11N in humans: the lumed phase 0b study. EJNMMI Research, 14(1). https://doi.org/10.1186/s13550-024-01101-w
Schulte, Janine, Hotz, Gerhard, Szinnai, Gabor, , Foderà, Gaspare, Krüsi, Karl, Nussberger, Peter, Kron, Sarah, & Schulz, Iris. (2024). Exploring the potential of genetic analysis in historical blood spots for patients with iodine-deficient goiter and thyroid carcinomas in Switzerland and Germany (1929–1989). BMC Medical Genomics, 17(1). https://doi.org/10.1186/s12920-024-01947-y
Schulte, Janine, Hotz, Gerhard, Szinnai, Gabor, , Foderà, Gaspare, Krüsi, Karl, Nussberger, Peter, Kron, Sarah, & Schulz, Iris. (2024). Exploring the potential of genetic analysis in historical blood spots for patients with iodine-deficient goiter and thyroid carcinomas in Switzerland and Germany (1929–1989). BMC Medical Genomics, 17(1). https://doi.org/10.1186/s12920-024-01947-y
Andereggen, L., & Christ, E. (2024). Letter to the Editor From Andereggen and Christ: “Clinical Characteristics and Outcomes of Prolactinomas in Children and Adolescents: A Large Retrospective Cohort Study” [Journal-article]. Journal of Clinical Endocrinology and Metabolism, 109(10), e1960–e1961. https://doi.org/10.1210/clinem/dgae383
Andereggen, L., & Christ, E. (2024). Letter to the Editor From Andereggen and Christ: “Clinical Characteristics and Outcomes of Prolactinomas in Children and Adolescents: A Large Retrospective Cohort Study” [Journal-article]. Journal of Clinical Endocrinology and Metabolism, 109(10), e1960–e1961. https://doi.org/10.1210/clinem/dgae383
Fricke, Julia, Westerbergh, Frida, McDougall, Lisa, Favaretto, Chiara, , Nicolas, Guillaume P., Geistlich, Susanne, Borgna, Francesca, Fani, Melpomeni, Bernhardt, Peter, van der Meulen, Nicholas P., Müller, Cristina, Schibli, Roger, & Wild, Damian. (2024). First-in-human administration of terbium-161-labelled somatostatin receptor subtype 2 antagonist ([161Tb]Tb-DOTA-LM3) in a patient with a metastatic neuroendocrine tumour of the ileum. European Journal of Nuclear Medicine and Molecular Imaging, 51(8), 2517–2519. https://doi.org/10.1007/s00259-024-06641-w
Fricke, Julia, Westerbergh, Frida, McDougall, Lisa, Favaretto, Chiara, , Nicolas, Guillaume P., Geistlich, Susanne, Borgna, Francesca, Fani, Melpomeni, Bernhardt, Peter, van der Meulen, Nicholas P., Müller, Cristina, Schibli, Roger, & Wild, Damian. (2024). First-in-human administration of terbium-161-labelled somatostatin receptor subtype 2 antagonist ([161Tb]Tb-DOTA-LM3) in a patient with a metastatic neuroendocrine tumour of the ileum. European Journal of Nuclear Medicine and Molecular Imaging, 51(8), 2517–2519. https://doi.org/10.1007/s00259-024-06641-w
Ebrahimi, Fahim, Andereggen, Lukas, & (2024). Morbidities and mortality among hospitalized patients with hypopituitarism: Prevalence, causes and management. Reviews in Endocrine and Metabolic Disorders, 25(3), 599–608. https://doi.org/10.1007/s11154-024-09888-8
Ebrahimi, Fahim, Andereggen, Lukas, & (2024). Morbidities and mortality among hospitalized patients with hypopituitarism: Prevalence, causes and management. Reviews in Endocrine and Metabolic Disorders, 25(3), 599–608. https://doi.org/10.1007/s11154-024-09888-8
Hofland, Johannes, Refardt, Julie C., Feelders, Richard A., , & de Herder, Wouter W. (2024). Approach to the Patient: Insulinoma [Journal-article]. Journal of Clinical Endocrinology and Metabolism, 109(4), 1109–1118. https://doi.org/10.1210/clinem/dgad641
Hofland, Johannes, Refardt, Julie C., Feelders, Richard A., , & de Herder, Wouter W. (2024). Approach to the Patient: Insulinoma [Journal-article]. Journal of Clinical Endocrinology and Metabolism, 109(4), 1109–1118. https://doi.org/10.1210/clinem/dgad641
Beck, Julia, Siebenhüner, Alexander, Wild, Damian, , & Refardt, Julie. (2024). Impact of sex on treatment decisions and outcome in patients with neuroendocrine neoplasms. Endocrine-Related Cancer, 31(3). https://doi.org/10.1530/erc-23-0235
Beck, Julia, Siebenhüner, Alexander, Wild, Damian, , & Refardt, Julie. (2024). Impact of sex on treatment decisions and outcome in patients with neuroendocrine neoplasms. Endocrine-Related Cancer, 31(3). https://doi.org/10.1530/erc-23-0235
Friebe, Liene, Freitag, Martin T., Braun, Martin, Nicolas, Guillaume, Bauman, Andreas, Bushnell, David, , & Wild, Damian. (2024). Peptide Receptor Radionuclide Therapy Is Effective for Clinical Control of Symptomatic Metastatic Insulinoma: A Long-Term Retrospective Analysis. Journal of Nuclear Medicine, 65(2), 228–235. https://doi.org/10.2967/jnumed.123.265894
Friebe, Liene, Freitag, Martin T., Braun, Martin, Nicolas, Guillaume, Bauman, Andreas, Bushnell, David, , & Wild, Damian. (2024). Peptide Receptor Radionuclide Therapy Is Effective for Clinical Control of Symptomatic Metastatic Insulinoma: A Long-Term Retrospective Analysis. Journal of Nuclear Medicine, 65(2), 228–235. https://doi.org/10.2967/jnumed.123.265894
Ambrosini, Valentina, Caplin, Martyn, Castaño, Justo P., , Denecke, Timm, Deroose, Christophe M., Dromain, Clarisse, Falconi, Massimo, Grozinsky-Glasberg, Simona, Hicks, Rodney J., Hofland, Johannes, Kjaer, Andreas, Knigge, Ulrich Peter, Kos-Kudla, Beata, Koumarianou, Anna, Krishna, Balkundi, Lamarca, Angela, Pavel, Marianne, Reed, Nicholas Simon, et al. (2024). Use and perceived utility of [18F]FDG PET/CT in neuroendocrine neoplasms: A consensus report from the European Neuroendocrine Tumor Society (ENETS) Advisory Board Meeting 2022. Journal of Neuroendocrinology, 36(1). https://doi.org/10.1111/jne.13359
Ambrosini, Valentina, Caplin, Martyn, Castaño, Justo P., , Denecke, Timm, Deroose, Christophe M., Dromain, Clarisse, Falconi, Massimo, Grozinsky-Glasberg, Simona, Hicks, Rodney J., Hofland, Johannes, Kjaer, Andreas, Knigge, Ulrich Peter, Kos-Kudla, Beata, Koumarianou, Anna, Krishna, Balkundi, Lamarca, Angela, Pavel, Marianne, Reed, Nicholas Simon, et al. (2024). Use and perceived utility of [18F]FDG PET/CT in neuroendocrine neoplasms: A consensus report from the European Neuroendocrine Tumor Society (ENETS) Advisory Board Meeting 2022. Journal of Neuroendocrinology, 36(1). https://doi.org/10.1111/jne.13359
Andereggen, Lukas, & . (2024). Commentary: Clinical characteristics of male prolactinoma patients mainly presenting with severe obesity and the metabolic response to dopamine agonist therapy. Frontiers in Endocrinology, 15. https://doi.org/10.3389/fendo.2024.1371468
Andereggen, Lukas, & . (2024). Commentary: Clinical characteristics of male prolactinoma patients mainly presenting with severe obesity and the metabolic response to dopamine agonist therapy. Frontiers in Endocrinology, 15. https://doi.org/10.3389/fendo.2024.1371468
Andereggen, Lukas, & . (2024). Commentary: Postoperative hypothalamic-pituitary dysfunction and long-term hormone replacement in patients with childhood-onset craniopharyngioma. Frontiers in Endocrinology, 15. https://doi.org/10.3389/fendo.2024.1371424
Andereggen, Lukas, & . (2024). Commentary: Postoperative hypothalamic-pituitary dysfunction and long-term hormone replacement in patients with childhood-onset craniopharyngioma. Frontiers in Endocrinology, 15. https://doi.org/10.3389/fendo.2024.1371424
Huber, Markus, Luedi, Markus M., Schubert, Gerrit A., Musahl, Christian, Tortora, Angelo, Frey, Janine, Beck, Jürgen, Mariani, Luigi, , & Andereggen, Lukas. (2024). Gender-specific prolactin thresholds to determine prolactinoma size: a novel Bayesian approach and its clinical utility. Frontiers in Surgery, 11. https://doi.org/10.3389/fsurg.2024.1363431
Huber, Markus, Luedi, Markus M., Schubert, Gerrit A., Musahl, Christian, Tortora, Angelo, Frey, Janine, Beck, Jürgen, Mariani, Luigi, , & Andereggen, Lukas. (2024). Gender-specific prolactin thresholds to determine prolactinoma size: a novel Bayesian approach and its clinical utility. Frontiers in Surgery, 11. https://doi.org/10.3389/fsurg.2024.1363431
Borisov, Angel N., Kutz, Alexander, , Heim, Markus H., & Ebrahimi, Fahim. (2023). Canagliflozin and Metabolic Associated Fatty Liver Disease in Patients With Diabetes Mellitus: New Insights From CANVAS. Journal of Clinical Endocrinology and Metabolism, 108(11), 2940–2949. https://doi.org/10.1210/clinem/dgad249
Borisov, Angel N., Kutz, Alexander, , Heim, Markus H., & Ebrahimi, Fahim. (2023). Canagliflozin and Metabolic Associated Fatty Liver Disease in Patients With Diabetes Mellitus: New Insights From CANVAS. Journal of Clinical Endocrinology and Metabolism, 108(11), 2940–2949. https://doi.org/10.1210/clinem/dgad249
Christ, E., Iacovazzo, D., Korbonits, M., & Perren, A. (2023). Insulinomatosis: new aspects. Endocrine-Related Cancer, 30(6). https://doi.org/10.1530/erc-22-0327
Christ, E., Iacovazzo, D., Korbonits, M., & Perren, A. (2023). Insulinomatosis: new aspects. Endocrine-Related Cancer, 30(6). https://doi.org/10.1530/erc-22-0327
Burman P., Trouillas J., Losa M., McCormack A., Petersenn S., Popovic V., Theodoropoulou M., Raverot G., Dekkers O.M., Guenego A., Micko A., Hubalewska-Dydejezky A., Troendle A., McCormack A., Rasmussen A.K., Whitelaw B., Decoudier B., Ekman B., Engstrom B.E., et al. (2022). Aggressive pituitary tumours and carcinomas, characteristics and management of 171 patients. European Journal of Endocrinology, 187(4), 593–605. https://doi.org/10.1530/eje-22-0440
Burman P., Trouillas J., Losa M., McCormack A., Petersenn S., Popovic V., Theodoropoulou M., Raverot G., Dekkers O.M., Guenego A., Micko A., Hubalewska-Dydejezky A., Troendle A., McCormack A., Rasmussen A.K., Whitelaw B., Decoudier B., Ekman B., Engstrom B.E., et al. (2022). Aggressive pituitary tumours and carcinomas, characteristics and management of 171 patients. European Journal of Endocrinology, 187(4), 593–605. https://doi.org/10.1530/eje-22-0440
Ebrahimi, Fahim, Kutz, Alexander, , & Szinnai, Gabor. (2022). Lifetime risk and health-care burden of diabetic ketoacidosis: A population-based study. Frontiers in Endocrinology, 13. https://doi.org/10.3389/fendo.2022.940990
Ebrahimi, Fahim, Kutz, Alexander, , & Szinnai, Gabor. (2022). Lifetime risk and health-care burden of diabetic ketoacidosis: A population-based study. Frontiers in Endocrinology, 13. https://doi.org/10.3389/fendo.2022.940990
, Czock A, Renström F, Ammeter T, Ebrahimi F, Zechmann S, Kutz A, Diem P, Häuptle C, & Brändle M. (2022). Evaluation of type 2 diabetes care management in nine primary care practices before and after implementation of the Criteria of Good Disease Management of Diabetes established by the Swiss Society of Endocrinology and Diabetology. Swiss Medical Weekly, 152(2930), w30197. https://doi.org/10.4414/smw.2022.w30197
, Czock A, Renström F, Ammeter T, Ebrahimi F, Zechmann S, Kutz A, Diem P, Häuptle C, & Brändle M. (2022). Evaluation of type 2 diabetes care management in nine primary care practices before and after implementation of the Criteria of Good Disease Management of Diabetes established by the Swiss Society of Endocrinology and Diabetology. Swiss Medical Weekly, 152(2930), w30197. https://doi.org/10.4414/smw.2022.w30197
Refardt J, Hofland J, Wild D., & . (2022). Molecular Imaging of Neuroendocrine Neoplasms. Journal of Clinical Endocrinology and Metabolism, 107(7), E2662–E2670. https://doi.org/10.1210/clinem/dgac207
Refardt J, Hofland J, Wild D., & . (2022). Molecular Imaging of Neuroendocrine Neoplasms. Journal of Clinical Endocrinology and Metabolism, 107(7), E2662–E2670. https://doi.org/10.1210/clinem/dgac207
Borbath I, Garcia-Carbonero R, Bikmukhametov D, Jimenez-Fonseca P, Castaño A, Barkmanova J, Sedlackova E, Kollár A, , Kaltsas G, Kos-Kudla B, Maasberg S, Verslype C, & Pape UF. (2022). The European Neuroendocrine Tumour Society registry, a tool to assess the prognosis of neuroendocrine neoplasms. European Journal of Cancer, 168, 80–90. https://doi.org/10.1016/j.ejca.2022.03.007
Borbath I, Garcia-Carbonero R, Bikmukhametov D, Jimenez-Fonseca P, Castaño A, Barkmanova J, Sedlackova E, Kollár A, , Kaltsas G, Kos-Kudla B, Maasberg S, Verslype C, & Pape UF. (2022). The European Neuroendocrine Tumour Society registry, a tool to assess the prognosis of neuroendocrine neoplasms. European Journal of Cancer, 168, 80–90. https://doi.org/10.1016/j.ejca.2022.03.007
, Wild D, & Refardt J. (2022). Molecular Imaging in neuroendocrine neoplasias. Presse Medicale, 51(2), 104115. https://doi.org/10.1016/j.lpm.2022.104115
, Wild D, & Refardt J. (2022). Molecular Imaging in neuroendocrine neoplasias. Presse Medicale, 51(2), 104115. https://doi.org/10.1016/j.lpm.2022.104115
Koehler V.F., Fuss CT, Berr C.M., Frank-Raue K., Raue F., Hoster E, Hepprich M., , Pusl T., Reincke M, Spitzweg C., & Kroiss M. (2022). Medullary thyroid cancer with ectopic Cushing’s syndrome: A multicentre case series. Clinical Endocrinology, 96(6), 847–856. https://doi.org/10.1111/cen.14617
Koehler V.F., Fuss CT, Berr C.M., Frank-Raue K., Raue F., Hoster E, Hepprich M., , Pusl T., Reincke M, Spitzweg C., & Kroiss M. (2022). Medullary thyroid cancer with ectopic Cushing’s syndrome: A multicentre case series. Clinical Endocrinology, 96(6), 847–856. https://doi.org/10.1111/cen.14617
Hofland J, Lamarca A, Steeds R, Toumpanakis C, Srirajaskanthan R, Riechelmann R, Panzuto F, Frilling A, Denecke T, , Grozinsky-Glasberg S, Davar J, & ENETS Carcinoid Heart Disease Task Force. (2022). Synoptic reporting of echocardiography in carcinoid heart disease (ENETS Carcinoid Heart Disease Task Force). Journal of Neuroendocrinology, 34(3), e13060. https://doi.org/10.1111/jne.13060
Hofland J, Lamarca A, Steeds R, Toumpanakis C, Srirajaskanthan R, Riechelmann R, Panzuto F, Frilling A, Denecke T, , Grozinsky-Glasberg S, Davar J, & ENETS Carcinoid Heart Disease Task Force. (2022). Synoptic reporting of echocardiography in carcinoid heart disease (ENETS Carcinoid Heart Disease Task Force). Journal of Neuroendocrinology, 34(3), e13060. https://doi.org/10.1111/jne.13060
Huber M., Luedi MM, Schubert G.A., Musahl C, Tortora A, Frey J, Beck J., Mariani L., , & Andereggen L. (2022). Machine Learning for Outcome Prediction in First-Line Surgery of Prolactinomas. Frontiers in Endocrinology, 13. https://doi.org/10.3389/fendo.2022.810219
Huber M., Luedi MM, Schubert G.A., Musahl C, Tortora A, Frey J, Beck J., Mariani L., , & Andereggen L. (2022). Machine Learning for Outcome Prediction in First-Line Surgery of Prolactinomas. Frontiers in Endocrinology, 13. https://doi.org/10.3389/fendo.2022.810219
Fawcett C, Eppenberger-Castori S, Zechmann S, Hanke J, Herzog M, Savic Prince S, , & Ebrahimi F. (2022). Effects of Rapid On-Site Evaluation on Diagnostic Accuracy of Thyroid Fine-Needle Aspiration. Acta Cytologica, 66(5), 371–378. https://doi.org/10.1159/000522662
Fawcett C, Eppenberger-Castori S, Zechmann S, Hanke J, Herzog M, Savic Prince S, , & Ebrahimi F. (2022). Effects of Rapid On-Site Evaluation on Diagnostic Accuracy of Thyroid Fine-Needle Aspiration. Acta Cytologica, 66(5), 371–378. https://doi.org/10.1159/000522662
Andereggen L., Frey J., Andres R.H., Luedi M.M., El-Koussy M., Widmer H.R., Beck J, Mariani L., Seiler R.W., & . (2021). First-line surgery in prolactinomas: lessons from a long-term follow-up study in a tertiary referral center. Journal of Endocrinological Investigation, 44(12), 2621–2633. https://doi.org/10.1007/s40618-021-01569-6
Andereggen L., Frey J., Andres R.H., Luedi M.M., El-Koussy M., Widmer H.R., Beck J, Mariani L., Seiler R.W., & . (2021). First-line surgery in prolactinomas: lessons from a long-term follow-up study in a tertiary referral center. Journal of Endocrinological Investigation, 44(12), 2621–2633. https://doi.org/10.1007/s40618-021-01569-6
Andereggen L., Frey J, Andres R.H., Luedi M.M., Widmer H.R., Beck J, Mariani L., & . (2021). Persistent bone impairment despite long-term control of hyperprolactinemia and hypogonadism in men and women with prolactinomas. Scientific Reports, 11(1). https://doi.org/10.1038/s41598-021-84606-x
Andereggen L., Frey J, Andres R.H., Luedi M.M., Widmer H.R., Beck J, Mariani L., & . (2021). Persistent bone impairment despite long-term control of hyperprolactinemia and hypogonadism in men and women with prolactinomas. Scientific Reports, 11(1). https://doi.org/10.1038/s41598-021-84606-x
Ebrahimi F., Urwyler S.A., Betz M.J., , Schuetz P., Mueller B., Donath M.Y., & Christ-Crain M. (2021). Effects of interleukin-1 antagonism and corticosteroids on fibroblast growth factor-21 in patients with metabolic syndrome. Scientific Reports, 11(1). https://doi.org/10.1038/s41598-021-87207-w
Ebrahimi F., Urwyler S.A., Betz M.J., , Schuetz P., Mueller B., Donath M.Y., & Christ-Crain M. (2021). Effects of interleukin-1 antagonism and corticosteroids on fibroblast growth factor-21 in patients with metabolic syndrome. Scientific Reports, 11(1). https://doi.org/10.1038/s41598-021-87207-w
Refardt J, Hofland J, Wild D, & . (2021). New Directions in Imaging Neuroendocrine Neoplasms. Current Oncology Reports, 23(12), 143. https://doi.org/10.1007/s11912-021-01139-2
Refardt J, Hofland J, Wild D, & . (2021). New Directions in Imaging Neuroendocrine Neoplasms. Current Oncology Reports, 23(12), 143. https://doi.org/10.1007/s11912-021-01139-2
Theiler D., Cattaneo M, Dierickx L.O., Igaz P., Grozinsky-Glasberg S, Bournaud C., O’dorisio T., Sue O’Dorisio M., Wild D., , & Nicolas GP. (2021). Safety and efficacy of peptide-receptor radionuclide therapy in elderly neuroendocrine tumor patients. Cancers, 13(24). https://doi.org/10.3390/cancers13246290
Theiler D., Cattaneo M, Dierickx L.O., Igaz P., Grozinsky-Glasberg S, Bournaud C., O’dorisio T., Sue O’Dorisio M., Wild D., , & Nicolas GP. (2021). Safety and efficacy of peptide-receptor radionuclide therapy in elderly neuroendocrine tumor patients. Cancers, 13(24). https://doi.org/10.3390/cancers13246290
Walter M.A., Nesti C, Spanjol M, Kollár A, Bütikofer L, Gloy VL, Dumont RA, Seiler CA, , Radojewski P, Briel M, & Kaderli RM. (2021). Treatment for gastrointestinal and pancreatic neuroendocrine tumours: a network meta-analysis. Cochrane Database of Systematic Reviews, 2021(11). https://doi.org/10.1002/14651858.cd013700.pub2
Walter M.A., Nesti C, Spanjol M, Kollár A, Bütikofer L, Gloy VL, Dumont RA, Seiler CA, , Radojewski P, Briel M, & Kaderli RM. (2021). Treatment for gastrointestinal and pancreatic neuroendocrine tumours: a network meta-analysis. Cochrane Database of Systematic Reviews, 2021(11). https://doi.org/10.1002/14651858.cd013700.pub2
Andereggen L., Mariani L., Beck J, Andres R.H., Gralla J., Luedi M.M., Weis J., & . (2021). Lateral one-third gland resection in Cushing patients with failed adenoma identification leads to low remission rates: long-term observations from a small, single-center cohort. Acta Neurochirurgica, 163(11), 3161–3169. https://doi.org/10.1007/s00701-021-04830-2
Andereggen L., Mariani L., Beck J, Andres R.H., Gralla J., Luedi M.M., Weis J., & . (2021). Lateral one-third gland resection in Cushing patients with failed adenoma identification leads to low remission rates: long-term observations from a small, single-center cohort. Acta Neurochirurgica, 163(11), 3161–3169. https://doi.org/10.1007/s00701-021-04830-2
Berkmann S, Brun J., Schuetz P., , Mariani L., & Mueller B. (2021). Prevalence and outcome of comorbidities associated with acromegaly. Acta Neurochirurgica, 163(11), 3171–3180. https://doi.org/10.1007/s00701-021-04846-8
Berkmann S, Brun J., Schuetz P., , Mariani L., & Mueller B. (2021). Prevalence and outcome of comorbidities associated with acromegaly. Acta Neurochirurgica, 163(11), 3171–3180. https://doi.org/10.1007/s00701-021-04846-8
Gut L, Bernet S, Huembelin M, Mueller M, Baechli C, Koch D, Nebiker C, Schuetz P, Mueller B, , Ebrahimi F, & Kutz A. (2021). Sex-Specific Differences in Outcomes following Thyroidectomy: A Population-Based Cohort Study. European Thyroid Journal, 10(6), 476–485. https://doi.org/10.1159/000510618
Gut L, Bernet S, Huembelin M, Mueller M, Baechli C, Koch D, Nebiker C, Schuetz P, Mueller B, , Ebrahimi F, & Kutz A. (2021). Sex-Specific Differences in Outcomes following Thyroidectomy: A Population-Based Cohort Study. European Thyroid Journal, 10(6), 476–485. https://doi.org/10.1159/000510618
Mueller M., Ebrahimi F., , Nebiker C.A., Schuetz P., Mueller B., & Kutz A. (2021). Safety of parathyroidectomy in older vs. younger patients with primary hyperparathyroidism. Endocrine Connections, 10(10), 1273–1282. https://doi.org/10.1530/ec-21-0363
Mueller M., Ebrahimi F., , Nebiker C.A., Schuetz P., Mueller B., & Kutz A. (2021). Safety of parathyroidectomy in older vs. younger patients with primary hyperparathyroidism. Endocrine Connections, 10(10), 1273–1282. https://doi.org/10.1530/ec-21-0363
Refardt J, Hofland J, Kwadwo A, Nicolas GP, Rottenburger C, Fani M, Wild D, & . (2021). Theranostics in neuroendocrine tumors: an overview of current approaches and future challenges. Reviews in Endocrine and Metabolic Disorders, 22(3), 581–594. https://doi.org/10.1007/s11154-020-09552-x
Refardt J, Hofland J, Kwadwo A, Nicolas GP, Rottenburger C, Fani M, Wild D, & . (2021). Theranostics in neuroendocrine tumors: an overview of current approaches and future challenges. Reviews in Endocrine and Metabolic Disorders, 22(3), 581–594. https://doi.org/10.1007/s11154-020-09552-x
Andereggen L, Beck J, Gralla J, Luedi MM, & . (2021). Letter to the Editor from Lukas Andereggen: “Pitfalls in Performing and Interpreting Inferior Petrosal Sinus Sampling: Personal Experience and Literature Review” (Patent No. 8). Journal of Clinical Endocrinology and Metabolism, 106(8), Article 8. https://doi.org/10.1210/clinem/dgab329
Andereggen L, Beck J, Gralla J, Luedi MM, & . (2021). Letter to the Editor from Lukas Andereggen: “Pitfalls in Performing and Interpreting Inferior Petrosal Sinus Sampling: Personal Experience and Literature Review” (Patent No. 8). Journal of Clinical Endocrinology and Metabolism, 106(8), Article 8. https://doi.org/10.1210/clinem/dgab329
Wild D, Antwi K, Fani M, & . (2021). Glucagon-like Peptide-1 Receptor as Emerging Target: Will It Make It to the Clinic? Journal of Nuclear Medicine, 62(Suppl 2), 44S–50S. https://doi.org/10.2967/jnumed.120.246009
Wild D, Antwi K, Fani M, & . (2021). Glucagon-like Peptide-1 Receptor as Emerging Target: Will It Make It to the Clinic? Journal of Nuclear Medicine, 62(Suppl 2), 44S–50S. https://doi.org/10.2967/jnumed.120.246009
Antwi K, Wiesner P., Merkle E.M., Zech CJ, Boll DT, Wild D, , & Heye T. (2021). Research article investigating difficult to detect pancreatic lesions: Characterization of benign pancreatic islet cell tumors using multiparametric pancreatic 3-T MRI. PLoS ONE, 16(6 June 2021), e0253078. https://doi.org/10.1371/journal.pone.0253078
Antwi K, Wiesner P., Merkle E.M., Zech CJ, Boll DT, Wild D, , & Heye T. (2021). Research article investigating difficult to detect pancreatic lesions: Characterization of benign pancreatic islet cell tumors using multiparametric pancreatic 3-T MRI. PLoS ONE, 16(6 June 2021), e0253078. https://doi.org/10.1371/journal.pone.0253078
Andereggen L, & . (2021). Commentary: “Prolactinomas: Prognostic Factors of Early Remission After Transsphenoidal Surgery” [Frontiers Media S.A.]. Frontiers in Endocrinology, 12, 695498. https://doi.org/10.3389/fendo.2021.695498
Andereggen L, & . (2021). Commentary: “Prolactinomas: Prognostic Factors of Early Remission After Transsphenoidal Surgery” [Frontiers Media S.A.]. Frontiers in Endocrinology, 12, 695498. https://doi.org/10.3389/fendo.2021.695498
Andereggen L, Frey J, & . (2021). Long-term IGF-1 monitoring in prolactinoma patients treated with cabergoline might not be indicated. Endocrine, 72(1), 216–222. https://doi.org/10.1007/s12020-020-02557-1
Andereggen L, Frey J, & . (2021). Long-term IGF-1 monitoring in prolactinoma patients treated with cabergoline might not be indicated. Endocrine, 72(1), 216–222. https://doi.org/10.1007/s12020-020-02557-1
Andereggen L., Frey J., Andres R.H., Luedi M.M., Gralla J., Schubert G.A., Beck J, Mariani L., & . (2021). Impact of primary medical or surgical therapy on prolactinoma patients’ BMI and metabolic profile over the long-term. Journal of Clinical and Translational Endocrinology, 24. https://doi.org/10.1016/j.jcte.2021.100258
Andereggen L., Frey J., Andres R.H., Luedi M.M., Gralla J., Schubert G.A., Beck J, Mariani L., & . (2021). Impact of primary medical or surgical therapy on prolactinoma patients’ BMI and metabolic profile over the long-term. Journal of Clinical and Translational Endocrinology, 24. https://doi.org/10.1016/j.jcte.2021.100258
Andereggen L, Gralla J, Schroth G, Mordasini P, Andres RH, Widmer HR, Luedi MM, Kellner F, Beck J, Mariani L, Ozdoba C, & . (2021). Influence of inferior petrosal sinus drainage symmetry on detection of adenomas in Cushing’s syndrome. Journal of Neuroradiology, 48(1), 10–15. https://doi.org/10.1016/j.neurad.2019.05.004
Andereggen L, Gralla J, Schroth G, Mordasini P, Andres RH, Widmer HR, Luedi MM, Kellner F, Beck J, Mariani L, Ozdoba C, & . (2021). Influence of inferior petrosal sinus drainage symmetry on detection of adenomas in Cushing’s syndrome. Journal of Neuroradiology, 48(1), 10–15. https://doi.org/10.1016/j.neurad.2019.05.004
Hess, Gabriel Fridolin, Soysal, Savas Deniz, Nicolas, Guillaume, Bolli, Martin, Zech, Christoph Johannes, Tzankov, Alexandar, , Montemurro, Michael, & Kollmar, Otto. (2021). Surgical Strategy Based on Radiological 3D Reconstruction in a Giant Metastatic Neuroendocrine Tumor of the Pancreas: A Case Report of an Interdisciplinary Approach. Case Reports in Surgery, 2021. https://doi.org/10.1155/2021/8811155
Hess, Gabriel Fridolin, Soysal, Savas Deniz, Nicolas, Guillaume, Bolli, Martin, Zech, Christoph Johannes, Tzankov, Alexandar, , Montemurro, Michael, & Kollmar, Otto. (2021). Surgical Strategy Based on Radiological 3D Reconstruction in a Giant Metastatic Neuroendocrine Tumor of the Pancreas: A Case Report of an Interdisciplinary Approach. Case Reports in Surgery, 2021. https://doi.org/10.1155/2021/8811155
Martel-Duguech LM, Jorgensen JOL, Korbonits M, Johannsson G, Webb SM, Amadidou F, Mintziori G, Arosio M, Giavoli C, Badiu C, Boschetti M, Ferone D, Ricci Bitti S, Brue T, Albarel F, Cannavò S, Cotta OR, Carvalho D, Salazar D, et al. (2021). ESE audit on management of adult growth hormone deficiency in clinical practice. European Journal of Endocrinology, 184(2), 323–334. https://doi.org/10.1530/eje-20-1180
Martel-Duguech LM, Jorgensen JOL, Korbonits M, Johannsson G, Webb SM, Amadidou F, Mintziori G, Arosio M, Giavoli C, Badiu C, Boschetti M, Ferone D, Ricci Bitti S, Brue T, Albarel F, Cannavò S, Cotta OR, Carvalho D, Salazar D, et al. (2021). ESE audit on management of adult growth hormone deficiency in clinical practice. European Journal of Endocrinology, 184(2), 323–334. https://doi.org/10.1530/eje-20-1180
Reto M Kaderli, Marko Spanjol, Attila Kollár, , Lukas Bütikofer, Viktoria Gloy, Rebecca A Dumont, Christian A Seiler, Emanuel R Christ, , Matthias Briel, & Martin A Walter . (2020). Therapeutic Options for Neuroendocrine Tumors: A Systematic Review and Network Meta-analysis. JAMA Oncology.
Reto M Kaderli, Marko Spanjol, Attila Kollár, , Lukas Bütikofer, Viktoria Gloy, Rebecca A Dumont, Christian A Seiler, Emanuel R Christ, , Matthias Briel, & Martin A Walter . (2020). Therapeutic Options for Neuroendocrine Tumors: A Systematic Review and Network Meta-analysis. JAMA Oncology.
Ebrahimi F, Kutz A, Wagner U, Illigens B, Siepmann T, Schuetz P, Christ-Crain M, Mueller B, Mueller B, & . (2020). Excess Mortality among Hospitalized Patients with Hypopituitarism—A Population-Based, Matched-Cohort Study. Journal of Clinical Endocrinology and Metabolism, 105(11), 1–9. https://doi.org/10.1210/clinem/dgaa517
Ebrahimi F, Kutz A, Wagner U, Illigens B, Siepmann T, Schuetz P, Christ-Crain M, Mueller B, Mueller B, & . (2020). Excess Mortality among Hospitalized Patients with Hypopituitarism—A Population-Based, Matched-Cohort Study. Journal of Clinical Endocrinology and Metabolism, 105(11), 1–9. https://doi.org/10.1210/clinem/dgaa517
Refardt J, Zandee WT, Brabander T, Feelders RA, Franssen GJH, Hofland LJ, , de Herder WW, & Hofland J. (2020). Inferior outcome of neuroendocrine tumor patients negative on somatostatin receptor imaging. Endocrine-Related Cancer, 27(11), 615–624. https://doi.org/10.1530/erc-20-0340
Refardt J, Zandee WT, Brabander T, Feelders RA, Franssen GJH, Hofland LJ, , de Herder WW, & Hofland J. (2020). Inferior outcome of neuroendocrine tumor patients negative on somatostatin receptor imaging. Endocrine-Related Cancer, 27(11), 615–624. https://doi.org/10.1530/erc-20-0340
Antwi K, Hepprich M, Müller NA, Reubi JC, Fani M, Rottenburger C, Nicolas G, Kaul F, , & Wild D. (2020). Pitfalls in the Detection of Insulinomas With Glucagon-Like Peptide-1 Receptor Imaging. Clinical Nuclear Medicine, 45(9), E386–E392. https://doi.org/10.1097/rlu.0000000000003124
Antwi K, Hepprich M, Müller NA, Reubi JC, Fani M, Rottenburger C, Nicolas G, Kaul F, , & Wild D. (2020). Pitfalls in the Detection of Insulinomas With Glucagon-Like Peptide-1 Receptor Imaging. Clinical Nuclear Medicine, 45(9), E386–E392. https://doi.org/10.1097/rlu.0000000000003124
Walter M.A., Spanjol M., Kollar A., Butikofer L., Gloy V.L., Dumont R.A., Seiler C.A., , Radojewski P., Briel M., & Kaderli R.M. (2020). Treatment for gastrointestinal and pancreatic neuroendocrine tumours: a network meta-analysis. Cochrane Database of Systematic Reviews, 2020(8). https://doi.org/10.1002/14651858.cd013700
Walter M.A., Spanjol M., Kollar A., Butikofer L., Gloy V.L., Dumont R.A., Seiler C.A., , Radojewski P., Briel M., & Kaderli R.M. (2020). Treatment for gastrointestinal and pancreatic neuroendocrine tumours: a network meta-analysis. Cochrane Database of Systematic Reviews, 2020(8). https://doi.org/10.1002/14651858.cd013700
Merola E, Rinke A, Partelli S, Gress TM, Andreasi V, Kollár A, Perren A, , Panzuto F, Pascher A, Jann H, Arsenic R, Cremer B, Kaemmerer D, Kump P, Lipp RW, Agaimy A, Wiedenmann B, Falconi M, & Pavel ME. (2020). Surgery with Radical Intent: Is There an Indication for G3 Neuroendocrine Neoplasms? Annals of Surgical Oncology, 27(5), 1348–1355. https://doi.org/10.1245/s10434-019-08049-5
Merola E, Rinke A, Partelli S, Gress TM, Andreasi V, Kollár A, Perren A, , Panzuto F, Pascher A, Jann H, Arsenic R, Cremer B, Kaemmerer D, Kump P, Lipp RW, Agaimy A, Wiedenmann B, Falconi M, & Pavel ME. (2020). Surgery with Radical Intent: Is There an Indication for G3 Neuroendocrine Neoplasms? Annals of Surgical Oncology, 27(5), 1348–1355. https://doi.org/10.1245/s10434-019-08049-5
Rottenburger C, Nicolas GP, McDougall L, Kaul F, Cachovan M, Vija AH, Schibli R, Geistlich S, Schumann A, Rau T, Glatz K, Behe M, , & Wild D. (2020). Cholecystokinin 2 receptor agonist 177Lu-PP-F11N for radionuclide therapy of medullary thyroid carcinoma: Results of the lumed phase 0a study. Journal of Nuclear Medicine, 61(4), 520–523. https://doi.org/10.2967/jnumed.119.233031
Rottenburger C, Nicolas GP, McDougall L, Kaul F, Cachovan M, Vija AH, Schibli R, Geistlich S, Schumann A, Rau T, Glatz K, Behe M, , & Wild D. (2020). Cholecystokinin 2 receptor agonist 177Lu-PP-F11N for radionuclide therapy of medullary thyroid carcinoma: Results of the lumed phase 0a study. Journal of Nuclear Medicine, 61(4), 520–523. https://doi.org/10.2967/jnumed.119.233031
, Antwi K, Fani M, & Wild D. (2020). Innovative imaging of insulinoma: The end of sampling? a review. Endocrine-Related Cancer, 27(4), R79–R92. https://doi.org/10.1530/erc-19-0476
, Antwi K, Fani M, & Wild D. (2020). Innovative imaging of insulinoma: The end of sampling? a review. Endocrine-Related Cancer, 27(4), R79–R92. https://doi.org/10.1530/erc-19-0476
Felder,Susan, Zechmann,Stefan, Baur,Katharina, Seelig,Eleonora, , Holbro,Andreas, & Potlukova,Eliska. (2020). Central hypothyroidism as an adverse effect of bexarotene treatment for cutaneous T-cell lymphoma. Endocrine Abstracts, 70.
Felder,Susan, Zechmann,Stefan, Baur,Katharina, Seelig,Eleonora, , Holbro,Andreas, & Potlukova,Eliska. (2020). Central hypothyroidism as an adverse effect of bexarotene treatment for cutaneous T-cell lymphoma. Endocrine Abstracts, 70.
Fuchs, Philipp S., Lötscher, Jonas, Berkemeier, Caroline M., Hirsiger, Julia R., Ghosh, Adhideb, Li, Quan-Zhen, Deigendesch, Nikolaus, , Navarini, Alexander A., Recher, Mike, Daikeler, Thomas, Heijnen, Ingmar A. F. M., & Berger, Christoph T. (2020). Co-Occurrence of ANCA-Associated Vasculitis and Sjögren’s Syndrome in a Patient With Acromegaly: A Case Report and Retrospective Single-Center Review of Acromegaly Patients. Frontiers in Immunology, 11(11), 613130. https://doi.org/10.3389/fimmu.2020.613130
Fuchs, Philipp S., Lötscher, Jonas, Berkemeier, Caroline M., Hirsiger, Julia R., Ghosh, Adhideb, Li, Quan-Zhen, Deigendesch, Nikolaus, , Navarini, Alexander A., Recher, Mike, Daikeler, Thomas, Heijnen, Ingmar A. F. M., & Berger, Christoph T. (2020). Co-Occurrence of ANCA-Associated Vasculitis and Sjögren’s Syndrome in a Patient With Acromegaly: A Case Report and Retrospective Single-Center Review of Acromegaly Patients. Frontiers in Immunology, 11(11), 613130. https://doi.org/10.3389/fimmu.2020.613130
Hepprich M, Antwi K, Waser B, Reubi JC, Wild D, , & . (2020). Brunner’s Gland Hyperplasia in a Patient after Roux-Y Gastric Bypass: An Important Pitfall in GLP-1 Receptor Imaging [Hindawi Limited]. Case Reports in Endocrinology, 2020, 4510910. https://doi.org/10.1155/2020/4510910
Hepprich M, Antwi K, Waser B, Reubi JC, Wild D, , & . (2020). Brunner’s Gland Hyperplasia in a Patient after Roux-Y Gastric Bypass: An Important Pitfall in GLP-1 Receptor Imaging [Hindawi Limited]. Case Reports in Endocrinology, 2020, 4510910. https://doi.org/10.1155/2020/4510910
Zechmann,Stefan, Felder,Susan, , & Potlukova,Eliska: (2020). Idiopathic Hypoparathyroidism–An uncommon cause of a chest pain. Endocrine Abstracts, 70.
Zechmann,Stefan, Felder,Susan, , & Potlukova,Eliska: (2020). Idiopathic Hypoparathyroidism–An uncommon cause of a chest pain. Endocrine Abstracts, 70.
Dubach IL, , & Diem P. (2019). HbA1c-testing: Evaluation of two point-of-care analysers. Primary Care Diabetes, 13(6), 583–587. https://doi.org/10.1016/j.pcd.2019.05.007
Dubach IL, , & Diem P. (2019). HbA1c-testing: Evaluation of two point-of-care analysers. Primary Care Diabetes, 13(6), 583–587. https://doi.org/10.1016/j.pcd.2019.05.007
Antwi K, Nicolas G, Fani M, Heye T, Pattou F, Grossman A, Chanson P, Reubi JC, Perren A, Gloor B, Vogt DR, Wild D, & . (2019). Ga-Exendin-4 PET/CT Detects Insulinomas in Patients with Endogenous Hyperinsulinemic Hypoglycemia in MEN-1. Journal of Clinical Endocrinology and Metabolism, 104(12), 5843–5852. https://doi.org/10.1210/jc.2018-02754
Antwi K, Nicolas G, Fani M, Heye T, Pattou F, Grossman A, Chanson P, Reubi JC, Perren A, Gloor B, Vogt DR, Wild D, & . (2019). Ga-Exendin-4 PET/CT Detects Insulinomas in Patients with Endogenous Hyperinsulinemic Hypoglycemia in MEN-1. Journal of Clinical Endocrinology and Metabolism, 104(12), 5843–5852. https://doi.org/10.1210/jc.2018-02754
Antwi K, Nicolas G, Fani M, , & Wild D. (2019). Volume Replacement Fluid Demarks Benign Insulinoma with 68Ga-DOTA-Exendin-4 PET/CT. Clinical Nuclear Medicine, 44(5), E347–E348. https://doi.org/10.1097/rlu.0000000000002522
Antwi K, Nicolas G, Fani M, , & Wild D. (2019). Volume Replacement Fluid Demarks Benign Insulinoma with 68Ga-DOTA-Exendin-4 PET/CT. Clinical Nuclear Medicine, 44(5), E347–E348. https://doi.org/10.1097/rlu.0000000000002522
Kaderli RM, Spanjol M, Kollár A, Bütikofer L, Gloy V, Dumont RA, Seiler CA, , Radojewski P, Briel M, & Walter MA. (2019). Therapeutic Options for Neuroendocrine Tumors: A Systematic Review and Network Meta-analysis. JAMA Oncology, 5(4), 480–489. https://doi.org/10.1001/jamaoncol.2018.6720
Kaderli RM, Spanjol M, Kollár A, Bütikofer L, Gloy V, Dumont RA, Seiler CA, , Radojewski P, Briel M, & Walter MA. (2019). Therapeutic Options for Neuroendocrine Tumors: A Systematic Review and Network Meta-analysis. JAMA Oncology, 5(4), 480–489. https://doi.org/10.1001/jamaoncol.2018.6720
Kwadwo A, Guillaume N, Wild D, & . (2019). Erratum to: Molecular imaging for neuroendeocrine tumours. Swiss Medical Weekly, 149, w20076. https://doi.org/10.4414/smw.2019.20076
Kwadwo A, Guillaume N, Wild D, & . (2019). Erratum to: Molecular imaging for neuroendeocrine tumours. Swiss Medical Weekly, 149, w20076. https://doi.org/10.4414/smw.2019.20076
Zulewski H, Giovanella L, Bilz S, , Haldemann A, Steinert H, Weidner S, Oertli D, Triponez F, Clerici T, Minder A, Dettmer M, & Komminoth P. (2019). Multidisciplinary approach for risk-oriented treatment of low-risk papillary thyroid cancer in Switzerland. Swiss Medical Weekly, 149, w14700. https://doi.org/10.4414/smw.2019.14700
Zulewski H, Giovanella L, Bilz S, , Haldemann A, Steinert H, Weidner S, Oertli D, Triponez F, Clerici T, Minder A, Dettmer M, & Komminoth P. (2019). Multidisciplinary approach for risk-oriented treatment of low-risk papillary thyroid cancer in Switzerland. Swiss Medical Weekly, 149, w14700. https://doi.org/10.4414/smw.2019.14700
Antwi K, Nicolas G, Wild D, & . (2019). Molecular imaging for neuroendocrine tumours. Swiss Medical Weekly, 149(9-10), w20017. https://doi.org/10.4414/smw.2019.20017
Antwi K, Nicolas G, Wild D, & . (2019). Molecular imaging for neuroendocrine tumours. Swiss Medical Weekly, 149(9-10), w20017. https://doi.org/10.4414/smw.2019.20017
Daly AF, Rostomyan L, Betea D, Bonneville JF, Villa C, Pellegata NS, Waser B, Reubi JC, Waeber Stephan C, , & Beckers A. (2019). Aip-mutated acromegaly resistant to first-generation somatostatin analogs: Long-term control with pasireotide lar in two patients. Endocrine Connections, 8(4), 367–377. https://doi.org/10.1530/ec-19-0004
Daly AF, Rostomyan L, Betea D, Bonneville JF, Villa C, Pellegata NS, Waser B, Reubi JC, Waeber Stephan C, , & Beckers A. (2019). Aip-mutated acromegaly resistant to first-generation somatostatin analogs: Long-term control with pasireotide lar in two patients. Endocrine Connections, 8(4), 367–377. https://doi.org/10.1530/ec-19-0004
Meienberg, Fabian, Loher, Hannah, Bucher, Julie, Jenni, Stefan, Krüsi, Marion, Kreis, Roland, Boesch, Chris, Betz, Matthias Johannes, & . (2019). The effect of exercise on intramyocellular acetylcarnitine (AcCtn) concentration in adult growth hormone deficiency (GHD). Scientific Reports, 9(1), 19431. https://doi.org/10.1038/s41598-019-55942-w
Meienberg, Fabian, Loher, Hannah, Bucher, Julie, Jenni, Stefan, Krüsi, Marion, Kreis, Roland, Boesch, Chris, Betz, Matthias Johannes, & . (2019). The effect of exercise on intramyocellular acetylcarnitine (AcCtn) concentration in adult growth hormone deficiency (GHD). Scientific Reports, 9(1), 19431. https://doi.org/10.1038/s41598-019-55942-w
Rieben C., & (2019). Prolactin - What’s new?: Hyperprolactinemia - Etiology, diagnostics, therapy Prolaktin – Was gibt’s Neues? Schweizer Zeitschrift Fur Gynakologie, 24(2), 9–12.
Rieben C., & (2019). Prolactin - What’s new?: Hyperprolactinemia - Etiology, diagnostics, therapy Prolaktin – Was gibt’s Neues? Schweizer Zeitschrift Fur Gynakologie, 24(2), 9–12.
Antwi K, Fani M, Heye T, Nicolas G, Rottenburger C, Kaul F, Merkle E, Zech CJ, Boll D, Vogt DR, Gloor B, , & Wild D. (2018). Comparison of glucagon-like peptide-1 receptor (GLP-1R) PET/CT, SPECT/CT and 3T MRI for the localisation of occult insulinomas: evaluation of diagnostic accuracy in a prospective crossover imaging study. European Journal of Nuclear Medicine and Molecular Imaging, 45(13), 2318–2327. https://doi.org/10.1007/s00259-018-4101-5
Antwi K, Fani M, Heye T, Nicolas G, Rottenburger C, Kaul F, Merkle E, Zech CJ, Boll D, Vogt DR, Gloor B, , & Wild D. (2018). Comparison of glucagon-like peptide-1 receptor (GLP-1R) PET/CT, SPECT/CT and 3T MRI for the localisation of occult insulinomas: evaluation of diagnostic accuracy in a prospective crossover imaging study. European Journal of Nuclear Medicine and Molecular Imaging, 45(13), 2318–2327. https://doi.org/10.1007/s00259-018-4101-5
Valente LG, Antwi K, Nicolas GP, Wild D, & . (2018). Clinical presentation of 54 patients with endogenous hyperinsulinaemic hypoglycaemia: A neurological chameleon (observational study). Swiss Medical Weekly, 148(45-46), w14682. https://doi.org/10.4414/smw.2018.14682
Valente LG, Antwi K, Nicolas GP, Wild D, & . (2018). Clinical presentation of 54 patients with endogenous hyperinsulinaemic hypoglycaemia: A neurological chameleon (observational study). Swiss Medical Weekly, 148(45-46), w14682. https://doi.org/10.4414/smw.2018.14682
Loher H, Jenni S, Bucher J, Krüsi M, Kreis R, Boesch C, & . (2018). Impaired repletion of intramyocellular lipids in patients with growth hormone deficiency after a bout of aerobic exercise. Growth Hormone and IGF Research, 42-43, 32–39. https://doi.org/10.1016/j.ghir.2018.08.001
Loher H, Jenni S, Bucher J, Krüsi M, Kreis R, Boesch C, & . (2018). Impaired repletion of intramyocellular lipids in patients with growth hormone deficiency after a bout of aerobic exercise. Growth Hormone and IGF Research, 42-43, 32–39. https://doi.org/10.1016/j.ghir.2018.08.001
Hornemann T, Alecu I, Hagenbuch N, Zhakupova A, Cremonesi A, Gautschi M, Jung HH, Meienberg F, Bilz S, , Baumgartner MR, & Hochuli M. (2018). Disturbed sphingolipid metabolism with elevated 1-deoxysphingolipids in glycogen storage disease type I – A link to metabolic control. Molecular Genetics and Metabolism, 125(1-2), 73–78. https://doi.org/10.1016/j.ymgme.2018.07.003
Hornemann T, Alecu I, Hagenbuch N, Zhakupova A, Cremonesi A, Gautschi M, Jung HH, Meienberg F, Bilz S, , Baumgartner MR, & Hochuli M. (2018). Disturbed sphingolipid metabolism with elevated 1-deoxysphingolipids in glycogen storage disease type I – A link to metabolic control. Molecular Genetics and Metabolism, 125(1-2), 73–78. https://doi.org/10.1016/j.ymgme.2018.07.003
Fenske W, Refardt J, Chifu I, Schnyder I, Winzeler B, Drummond J, Ribeiro-Oliveira A Jr, Drescher T, Bilz S, Vogt DR, Malzahn U, Kroiss M, , Henzen C, Fischli S, Tönjes A, Mueller B, Schopohl J, Flitsch J, et al. (2018). A copeptin-based approach in the diagnosis of diabetes insipidus. New England Journal of Medicine, 379(5), 428–439. https://doi.org/10.1056/NEJMoa1803760
Fenske W, Refardt J, Chifu I, Schnyder I, Winzeler B, Drummond J, Ribeiro-Oliveira A Jr, Drescher T, Bilz S, Vogt DR, Malzahn U, Kroiss M, , Henzen C, Fischli S, Tönjes A, Mueller B, Schopohl J, Flitsch J, et al. (2018). A copeptin-based approach in the diagnosis of diabetes insipidus. New England Journal of Medicine, 379(5), 428–439. https://doi.org/10.1056/NEJMoa1803760
Nicolas GP, Schreiter N, Kaul F, Uiters J, Bouterfa H, Kaufmann J, Erlanger TE, Cathomas R, , Fani M, & Wild D. (2018). Sensitivity Comparison of (68)Ga-OPS202 and (68)Ga-DOTATOC PET/CT in Patients with Gastroenteropancreatic Neuroendocrine Tumors: A Prospective Phase II Imaging Study. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine, 59(6), 915–921. https://doi.org/10.2967/jnumed.117.199760
Nicolas GP, Schreiter N, Kaul F, Uiters J, Bouterfa H, Kaufmann J, Erlanger TE, Cathomas R, , Fani M, & Wild D. (2018). Sensitivity Comparison of (68)Ga-OPS202 and (68)Ga-DOTATOC PET/CT in Patients with Gastroenteropancreatic Neuroendocrine Tumors: A Prospective Phase II Imaging Study. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine, 59(6), 915–921. https://doi.org/10.2967/jnumed.117.199760
Andereggen L, Hess B, Andres R, El-Koussy M, Mariani L, Raabe A, Seiler RW, & . (2018). A ten-year follow-up study of treatment outcome of craniopharyngiomas. Swiss Medical Weekly, 148(5-6), w14521. https://doi.org/10.4414/smw.2017.14521
Andereggen L, Hess B, Andres R, El-Koussy M, Mariani L, Raabe A, Seiler RW, & . (2018). A ten-year follow-up study of treatment outcome of craniopharyngiomas. Swiss Medical Weekly, 148(5-6), w14521. https://doi.org/10.4414/smw.2017.14521
Andereggen L., Hess B., Andres R.H., El-Koussy M., Mariani L., Raabe A., Seiler R.W., & (2018). A ten-year follow-up study of treatment outcome of craniopharyngiomas. Swiss Medical Weekly, 148(5-6). https://doi.org/10.4414/smw.2017.14521
Andereggen L., Hess B., Andres R.H., El-Koussy M., Mariani L., Raabe A., Seiler R.W., & (2018). A ten-year follow-up study of treatment outcome of craniopharyngiomas. Swiss Medical Weekly, 148(5-6). https://doi.org/10.4414/smw.2017.14521
Körner M, Waser B, , Beck J, & Reubi JC. (2018). A Critical Evaluation of sst3 and sst5 Immunohistochemistry in Human Pituitary Adenomas. Neuroendocrinology, 106(2), 116–127. https://doi.org/10.1159/000472563
Körner M, Waser B, , Beck J, & Reubi JC. (2018). A Critical Evaluation of sst3 and sst5 Immunohistochemistry in Human Pituitary Adenomas. Neuroendocrinology, 106(2), 116–127. https://doi.org/10.1159/000472563
Iacovazzo D, Flanagan SE, Walker E, Quezado R, de Sousa Barros FA, Caswell R, Johnson MB, Wakeling M, Brändle M, Guo M, Dang MN, Gabrovska P, Niederle B, , Jenni S, Sipos B, Nieser M, Frilling A, Dhatariya K, et al. (2018). MAFA missense mutation causes familial insulinomatosis and diabetes mellitus. Proceedings of the National Academy of Sciences of the United States of America, 115(5), 1027–1032. https://doi.org/10.1073/pnas.1712262115
Iacovazzo D, Flanagan SE, Walker E, Quezado R, de Sousa Barros FA, Caswell R, Johnson MB, Wakeling M, Brändle M, Guo M, Dang MN, Gabrovska P, Niederle B, , Jenni S, Sipos B, Nieser M, Frilling A, Dhatariya K, et al. (2018). MAFA missense mutation causes familial insulinomatosis and diabetes mellitus. Proceedings of the National Academy of Sciences of the United States of America, 115(5), 1027–1032. https://doi.org/10.1073/pnas.1712262115
Notter A, Jenni S, & . (2018). Evaluation of the frequency of adrenal crises and preventive measures in patients with primary and secondary adrenal insufficiency in Switzerland. Swiss Medical Weekly, 148(3-4), w14586. https://doi.org/10.4414/smw.2018.14586
Notter A, Jenni S, & . (2018). Evaluation of the frequency of adrenal crises and preventive measures in patients with primary and secondary adrenal insufficiency in Switzerland. Swiss Medical Weekly, 148(3-4), w14586. https://doi.org/10.4414/smw.2018.14586
Sadowski SM, , Bédat B, Kollár A, Karenovics W, Perren A, Triponez F, & SwissNET registry. (2018). Nationwide multicenter study on the management of pulmonary neuroendocrine (carcinoid) tumors. Endocrine Connections, 7(1), 8–15. https://doi.org/10.1530/EC-17-0271
Sadowski SM, , Bédat B, Kollár A, Karenovics W, Perren A, Triponez F, & SwissNET registry. (2018). Nationwide multicenter study on the management of pulmonary neuroendocrine (carcinoid) tumors. Endocrine Connections, 7(1), 8–15. https://doi.org/10.1530/EC-17-0271
Andereggen L, Mono ML, Kellner-Weldon F, & . (2017). Cluster headache and macroprolactinoma: Case report of a rare, but potential important causality. Journal of Clinical Neuroscience, 40, 62–64. https://doi.org/10.1016/j.jocn.2017.01.028
Andereggen L, Mono ML, Kellner-Weldon F, & . (2017). Cluster headache and macroprolactinoma: Case report of a rare, but potential important causality. Journal of Clinical Neuroscience, 40, 62–64. https://doi.org/10.1016/j.jocn.2017.01.028
Andereggen L, Frey J, Andres RH, El-Koussy M, Beck J, Seiler RW, & . (2017). 10-year follow-up study comparing primary medical vs. surgical therapy in women with prolactinomas. Endocrine, 55(1), 223–230. https://doi.org/10.1007/s12020-016-1115-2
Andereggen L, Frey J, Andres RH, El-Koussy M, Beck J, Seiler RW, & . (2017). 10-year follow-up study comparing primary medical vs. surgical therapy in women with prolactinomas. Endocrine, 55(1), 223–230. https://doi.org/10.1007/s12020-016-1115-2
Andereggen L, Frey J, Andres RH, El-Koussy M, Beck J, Seiler RW, & . (2017). Long-Term Follow-Up of Primary Medical Versus Surgical Treatment of Prolactinomas in Men: Effects on Hyperprolactinemia, Hypogonadism, and Bone Health. World Neurosurgery, 97, 595–602. https://doi.org/10.1016/j.wneu.2016.10.059
Andereggen L, Frey J, Andres RH, El-Koussy M, Beck J, Seiler RW, & . (2017). Long-Term Follow-Up of Primary Medical Versus Surgical Treatment of Prolactinomas in Men: Effects on Hyperprolactinemia, Hypogonadism, and Bone Health. World Neurosurgery, 97, 595–602. https://doi.org/10.1016/j.wneu.2016.10.059
Antwi, A., Fani, M., Heye, T., Nicolas, G., Merkle, E., Reubi, J. C., Gloor, B., , & Wild, D. (2017). Sensitivity of Glucagon-Like Peptide-1 Receptor (GLP1-R) SPECT/CT, PET/CT and MRI for the Localization of Benign Insulinomas: Interim Analysis of a Prospective Imaging Efficacy Study. 105, 163. KARGER.
Antwi, A., Fani, M., Heye, T., Nicolas, G., Merkle, E., Reubi, J. C., Gloor, B., , & Wild, D. (2017). Sensitivity of Glucagon-Like Peptide-1 Receptor (GLP1-R) SPECT/CT, PET/CT and MRI for the Localization of Benign Insulinomas: Interim Analysis of a Prospective Imaging Efficacy Study. 105, 163. KARGER.
Loher H, Kreis R, Boesch C, & . (2016). The flexibility of ectopic lipids. International Journal of Molecular Sciences, 17(9). https://doi.org/10.3390/ijms17091554
Loher H, Kreis R, Boesch C, & . (2016). The flexibility of ectopic lipids. International Journal of Molecular Sciences, 17(9). https://doi.org/10.3390/ijms17091554
Zueger T, Loher H, Egger A, Boesch C, & . (2016). Regulation of fuel metabolism during exercise in hypopituitarism with growth hormone-deficiency (GHD). Growth Hormone and IGF Research, 29, 39–44. https://doi.org/10.1016/j.ghir.2016.03.007
Zueger T, Loher H, Egger A, Boesch C, & . (2016). Regulation of fuel metabolism during exercise in hypopituitarism with growth hormone-deficiency (GHD). Growth Hormone and IGF Research, 29, 39–44. https://doi.org/10.1016/j.ghir.2016.03.007
Cuthbertson DJ, Banks M, Khoo B, Antwi K, , Campbell F, Raraty M, & Wild D. (2016). Application of Ga68-DOTA-exendin-4 PET/CT to localize an occult insulinoma (Patent No. 5). Clinical Endocrinology, 84(5), Article 5. https://doi.org/10.1111/cen.12973
Cuthbertson DJ, Banks M, Khoo B, Antwi K, , Campbell F, Raraty M, & Wild D. (2016). Application of Ga68-DOTA-exendin-4 PET/CT to localize an occult insulinoma (Patent No. 5). Clinical Endocrinology, 84(5), Article 5. https://doi.org/10.1111/cen.12973
Trombetti A, , Henzen C, Gold G., Brändle M, Herrmann FR, Torriani C, Triponez F, Kraenzlin M, Rizzoli R, & Meier C. (2016). Clinical presentation and management of patients with primary hyperparathyroidism of the Swiss Primary Hyperparathyroidism Cohort: A focus on neuro-behavioral and cognitive symptoms. Journal of Endocrinological Investigation, 39(5), 567–576. https://doi.org/10.1007/s40618-015-0423-3
Trombetti A, , Henzen C, Gold G., Brändle M, Herrmann FR, Torriani C, Triponez F, Kraenzlin M, Rizzoli R, & Meier C. (2016). Clinical presentation and management of patients with primary hyperparathyroidism of the Swiss Primary Hyperparathyroidism Cohort: A focus on neuro-behavioral and cognitive symptoms. Journal of Endocrinological Investigation, 39(5), 567–576. https://doi.org/10.1007/s40618-015-0423-3
Jenni S, Adler M, Lanz S, Taleghani BM, & . (2016). Changes of Thyroid Hormones and Their Binding Proteins during Plasma Exchange for Polyneuropathy in a Patient with Substituted Hypothyroidism due to Hashimoto’s Thyroiditis. In Transfusion Medicine and Hemotherapy (No. 1; Transfusion Medicine and Hemotherapy, Vol. 43, pp. 45–49). S. Karger AG. https://doi.org/10.1159/000440822
Jenni S, Adler M, Lanz S, Taleghani BM, & . (2016). Changes of Thyroid Hormones and Their Binding Proteins during Plasma Exchange for Polyneuropathy in a Patient with Substituted Hypothyroidism due to Hashimoto’s Thyroiditis. In Transfusion Medicine and Hemotherapy (No. 1; Transfusion Medicine and Hemotherapy, Vol. 43, pp. 45–49). S. Karger AG. https://doi.org/10.1159/000440822
, Egger A, Allemann S, Buehler T, Kreis R, & Boesch C. (2016). Effects of aerobic exercise on ectopic lipids in patients with growth hormone deficiency before and after growth hormone replacement therapy. Scientific Reports, 6, 19310. https://doi.org/10.1038/srep19310
, Egger A, Allemann S, Buehler T, Kreis R, & Boesch C. (2016). Effects of aerobic exercise on ectopic lipids in patients with growth hormone deficiency before and after growth hormone replacement therapy. Scientific Reports, 6, 19310. https://doi.org/10.1038/srep19310
. (2016). Preface - Neuroendocrine tumours. Best Practice and Research: Clinical Endocrinology and Metabolism, 30(1), 1. https://doi.org/10.1016/j.beem.2016.02.011
. (2016). Preface - Neuroendocrine tumours. Best Practice and Research: Clinical Endocrinology and Metabolism, 30(1), 1. https://doi.org/10.1016/j.beem.2016.02.011
Kollár A, Blank A, Perren A, Bütikofer L, Stettler C, & . (2016). Additional malignancies in patients with neuroendocrine tumours: analysis of the SwissNET registry. Swiss Medical Weekly, 146, w14362. https://doi.org/10.4414/smw.2016.14362
Kollár A, Blank A, Perren A, Bütikofer L, Stettler C, & . (2016). Additional malignancies in patients with neuroendocrine tumours: analysis of the SwissNET registry. Swiss Medical Weekly, 146, w14362. https://doi.org/10.4414/smw.2016.14362
Nicolas, G., Schreiter, N., Kaul, F., Uiters, J., Mena, R., Bauman, A., Bouterfa, H., Reubi, J. C., Rivier, J., Maecke, H., Cathomas, R., , Fani, M., & Wild, D. (2016). Somatostatin Receptor PET/CT with Radiolabelled Antagonist Is Twice as Effective as the Agonist for Detecting Liver Metastases: Results of a Phase 1/2 Study Comparing 68Ga-OPS202 with 68Ga-DOTATOC PET/CT in Gastroenteropancreatic NET Patients. 103, 60. KARGER.
Nicolas, G., Schreiter, N., Kaul, F., Uiters, J., Mena, R., Bauman, A., Bouterfa, H., Reubi, J. C., Rivier, J., Maecke, H., Cathomas, R., , Fani, M., & Wild, D. (2016). Somatostatin Receptor PET/CT with Radiolabelled Antagonist Is Twice as Effective as the Agonist for Detecting Liver Metastases: Results of a Phase 1/2 Study Comparing 68Ga-OPS202 with 68Ga-DOTATOC PET/CT in Gastroenteropancreatic NET Patients. 103, 60. KARGER.
, Wild D, Antwi K, Waser B, Fani M, Schwanda S, Heye T, Schmid C, Baer HU, Perren A, & Reubi JC. (2015). Preoperative localization of adult nesidioblastosis using 68Ga-DOTA-exendin-4-PET/CT. Endocrine, 50(3), 821–823. https://doi.org/10.1007/s12020-015-0633-7
, Wild D, Antwi K, Waser B, Fani M, Schwanda S, Heye T, Schmid C, Baer HU, Perren A, & Reubi JC. (2015). Preoperative localization of adult nesidioblastosis using 68Ga-DOTA-exendin-4-PET/CT. Endocrine, 50(3), 821–823. https://doi.org/10.1007/s12020-015-0633-7
Galimov A, Hartung A, Trepp R, Mader A, Flück M, Linke A, Blüher M, , & Krützfeldt J. (2015). Growth hormone replacement therapy regulates microRNA-29a and targets involved in insulin resistance. Journal of Molecular Medicine, 93(12), 1369–1379. https://doi.org/10.1007/s00109-015-1322-y
Galimov A, Hartung A, Trepp R, Mader A, Flück M, Linke A, Blüher M, , & Krützfeldt J. (2015). Growth hormone replacement therapy regulates microRNA-29a and targets involved in insulin resistance. Journal of Molecular Medicine, 93(12), 1369–1379. https://doi.org/10.1007/s00109-015-1322-y
Kaderli RM, Fahrner R, , Stettler C, Fuhrer J, Martinelli M, Vogt A, & Seiler CA. (2015). Total Thyroidectomy for Amiodarone-induced Thyrotoxicosis in the Hyperthyroid State. Experimental and Clinical Endocrinology and Diabetes, 124(1), 45–48. https://doi.org/10.1055/s-0035-1565094
Kaderli RM, Fahrner R, , Stettler C, Fuhrer J, Martinelli M, Vogt A, & Seiler CA. (2015). Total Thyroidectomy for Amiodarone-induced Thyrotoxicosis in the Hyperthyroid State. Experimental and Clinical Endocrinology and Diabetes, 124(1), 45–48. https://doi.org/10.1055/s-0035-1565094
Locher R, Egger A, Zwimpfer C, Sze L, Schmid C, & . (2015). Effect of Growth hormone replacement therapy on soluble Klotho in patients with Growth hormone deficiency (Patent No. 4). Clinical Endocrinology, 83(4), Article 4. https://doi.org/10.1111/cen.12756
Locher R, Egger A, Zwimpfer C, Sze L, Schmid C, & . (2015). Effect of Growth hormone replacement therapy on soluble Klotho in patients with Growth hormone deficiency (Patent No. 4). Clinical Endocrinology, 83(4), Article 4. https://doi.org/10.1111/cen.12756